Femasys Inc is trading 5.6% down at $5.09 as the sharp mechanical jump from its recent 1-for-20 reverse stock split begins to lose momentum.
- The current price action follows the June 8 reverse split, which caused a technical surge that is now retracing in the absence of new company-specific operating developments.
- Broader market weakness is weighing on the stock, with the NASDAQ Composite dropping 3.52% and growth-oriented biotech stocks facing significant selling pressure.